The glycopeptide antibiotic A35512B was isolated from Streptomyces candidus NRRL 8156 as the major active factor. Chemical degradation studies showed that mild acid hydrolysis resulted in the release, one molecule each, of four neutral sugars: rhamnose, fucose, glucose and mannose, as well as the liberation of a complex peptide core which retained all the amino acids and from which 3-amino-2,3,6-trideoxy-3-C-methyl-L-.rylo-hexopyranose, a new amino sugar, was isolated (2). Oxidative degradation of A35512B resulted in the isolation of a chlorodiphenylether (5), dimethyl 4-methoxyisophthalate (7) and methyl 3,5-bis-(4-methoxycarbonylphenoxy)-4-methoxybenzoate (6). The structure of 5 could not be conclusively elucidated but was shown to be either 5-chloro-2',3-dimethoxy-2,5'-dicarbomethoxy diphenylether (5a) or 2-chloro-2',3-dimethoxy-5,5'-dicarbomethoxy diphenylether (5b) by physical methods. This halogenated fragment was shown to arise from oxidation of constituent amino acid (10) which has the aromatic substitution pattern of fragment (5a or 5b). Base hydrolysis resulted in the isolation of a phenanthridine (9) which arose from 2',4,6-trihydroxybiphenyl-2,5'-diyldiglycine. These chemical degradation studies on A35512B showed that this antibiotic is closely related to the ristocetin class of antibiotics.The antibacterial antibiotic complex A35512 is produced by Streptomyces candidus NRRL 8156 from which several closely related factors have been isolated and characterized by MICHEL.la> These antibiotics possess high antimicrobial activity against Gram-positive bacteria and are ineffective against Gram-negative organisms2).The A35512 complex has been shown to be a member of the glycopeptide family of antibiotics of which vancomycin, ristocetin and actinoidin are prominent members3). Characterization work by MICHEL showed that this complex was composed of six closely related factors.l8) Each of these factors contained the identical complex amino acids (amino acid analysis of 6 N HCl total hydrolyzate). The complex released neutral sugars and a complex peptide upon mild acid hydrolysis. The antibiotic complex had several phenolic groups (UV spectrum) and a complex titration curve. These data were consistent with the conclusion that A35512 represented a complex of new glycopeptide antibiotics.The major factor, A35512B, was obtained in crystalline form. The present paper will summarize the chemical studies on this antibiotic and relate it to other members of the glycopeptide class of antimicrobial agents.Chemical Properties of A35512B When A35512B was hydrolyzed under mild conditions (0.5 N HCl, 4 hours, refiux) an antimicrobially active aglycone I (1) was formed, and a number of neutral sugars were released. These sugars were identified by paper and thin-layer chromatography as rhamnose, glucose, fucose and mannose. This